Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine
April 16, 2014 at 14:02 PM EDT
Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today that final data from its Phase 1 study of CDX-1401 in solid tumors, including ...